Chemokine (C-C Motif) Receptor-Like 2 is Not Essential for Lung Injury, Lung Inflammation, or Airway Hyperresponsiveness Induced by Acute Exposure to Ozone
Overview
Authors
Affiliations
Inhalation of ozone (O), a gaseous air pollutant, causes lung injury, lung inflammation, and airway hyperresponsiveness. Macrophages, mast cells, and neutrophils contribute to one or more of these sequelae induced by O Furthermore, each of these aforementioned cells express chemokine (C-C motif) receptor-like 2 (Ccrl2), an atypical chemokine receptor that facilitates leukocyte chemotaxis. Given that Ccrl2 is expressed by cells essential to the development of O-induced lung pathology and that chemerin, a Ccrl2 ligand, is increased in bronchoalveolar lavage fluid (BALF) by O, we hypothesized that Ccrl2 contributes to the development of lung injury, lung inflammation, and airway hyperresponsiveness induced by O To that end, we measured indices of lung injury (BALF protein, BALF epithelial cells, and bronchiolar epithelial injury), lung inflammation (BALF cytokines and BALF leukocytes), and airway responsiveness to acetyl--methylcholine chloride (respiratory system resistance) in wild-type and mice genetically deficient in Ccrl2 (Ccrl2-deficient mice) 4 and/or 24 hours following cessation of acute exposure to either filtered room air (air) or O In air-exposed mice, BALF chemerin was greater in Ccrl2-deficient as compared to wild-type mice. O increased BALF chemerin in mice of both genotypes, yet following O exposure, BALF chemerin was greater in Ccrl2-deficient as compared to wild-type mice. O increased indices of lung injury, lung inflammation, and airway responsiveness. Nevertheless, no indices were different between genotypes following O exposure. In conclusion, we demonstrate that Ccrl2 modulates chemerin levels in the epithelial lining fluid of the lungs but does not contribute to the development of O-induced lung pathology.
Sex Differences in Energy Metabolism: A Female-Oriented Discussion.
Sanchez B, Volek J, Kraemer W, Saenz C, Maresh C Sports Med. 2024; 54(8):2033-2057.
PMID: 38888855 DOI: 10.1007/s40279-024-02063-8.
Johnston R, Pilkington 4th A, Atkins C, Boots T, Brown P, Jackson W Physiol Rep. 2024; 12(8):e16008.
PMID: 38631890 PMC: 11023814. DOI: 10.14814/phy2.16008.
The Dual Role of Chemerin in Lung Diseases.
Lavis P, Bondue B, Cardozo A Cells. 2024; 13(2).
PMID: 38247862 PMC: 10814516. DOI: 10.3390/cells13020171.
Su Z, Brooks J, Pelker J, Andreyeva T, Sobon H, Gifford R PLoS One. 2023; 18(1):e0280590.
PMID: 36662882 PMC: 9858354. DOI: 10.1371/journal.pone.0280590.
Johnston R, Atkins C, Siddiqui S, Jackson W, Mitchell N, Spencer C Am J Physiol Regul Integr Comp Physiol. 2022; 323(6):R921-R934.
PMID: 36283092 PMC: 9722265. DOI: 10.1152/ajpregu.00213.2022.